Suven Pharmaceuticals acquires majority stake in NJ Bio, strengthens US presence
Suven Pharmaceuticals Limited, a technology-focused contract development and manufacturing organisation (CDMO), has announced the acquisition of a controlling 56% stake in NJ Bio Inc., a ... Read More
Avid Bioservices to exit public market with GHO and Ampersand buyout
In a transformative shift within the biopharmaceutical manufacturing sector, Avid Bioservices, a premier biologics contract development and manufacturing organization (CDMO), has announced its agreement to ... Read More
Piramal Pharma posts robust Q2 growth, expands Lexington facility to meet demand
Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635) has reported strong growth for the second quarter (Q2) and first half (H1) of the fiscal year ... Read More
Glenmark Life Sciences’ Q1FY25 results shock industry with 9.7% revenue surge
Glenmark Life Sciences Limited (BSE: 543322, NSE: GLS), a prominent player in the pharmaceutical industry, has announced impressive financial results for the quarter ended June ... Read More
Lupin Limited appoints Abdelaziz Toumi as CEO of new subsidiary
Global pharmaceutical giant, Lupin Limited, announced the appointment of Abdelaziz Toumi (commonly known as Abdel) as the Chief Executive Officer of its newly established subsidiary, ... Read More
Vetter announces major global expansion with investments in US and Germany
Vetter, a leading global contract development and manufacturing organization (CDMO), has unveiled significant expansion plans, which include relocating and enlarging its Development Services site in ... Read More
Lonza to acquire Genentech’s biologics manufacturing facility in Vacaville for $1.2bn
In a strategic move that significantly escalates its capacity in the biologics manufacturing landscape, Lonza, a key global player in manufacturing for the pharmaceutical, biotech, ... Read More
Oxford Biomedica to acquire ABL Europe to expand global CDMO reach
Oxford Biomedica plc, a leading cell and gene therapy Contract Development and Manufacturing Organization (CDMO), is set to significantly enhance its global presence with the ... Read More
Indian CDMO Gland Pharma to acquire French CDMO Cenexi
Gland Pharma, an Indian contract development and manufacturing organization (CDMO), through its Singapore subsidiary Gland Pharma International, has agreed to acquire Cenexi, a French CDMO, ... Read More
Jubilant Ingrevia bags CDMO contract worth Rs 270cr
Jubilant Ingrevia, an Indian chemicals company, has bagged a contract development and manufacturing company (CDMO) contract with an estimated value of INR 270 crores for ... Read More